Ritleng®+ | Autostable Ritleng® Intubation

Interested?

Request more information about this product.

REQUEST INFO

FCI EXCLUSIVE

Description :

Ritleng®+ is FCI latest autostable bicanalicular nasolacrimal intubation indicated for epiphora, canalicular pathologies, congenital lacrimal duct obstruction and dacryocystorhinostomy (DCR). It consists of a silicone tube connected at each extremity to a PEEK thread guide. It is designed to reduce operating time and trauma for the patients, either in the intubation phase as well as for the removal of the device. The intubation is self-retaining thanks to two wider silicone portions on the silicone tube. The surgical procedure is similar to the conventional Ritleng® lacrimal intubation and involves the use of Ritleng® instruments.

Main characteristics :

  • Regular 0.64 mm silicone tube for a comfortable fit in the intrapalpebral loop
  • Wider 0.94 mm silicone segments to be positioned in the lacrimal sac ensuring the self-retaining feature of the intubation: no need to make knots in the nasal fossa
  • Blackmark to control the central placement and correct positioning of the silicone tube between the two punctums
  • Easy removal from the nose
  • Require Ritleng® instruments (S1.1460, S1.1470, S1.1480)

References

SKU DESIGNATION SIZE MATERIAL PACKAGING
S1.1456 Ritleng®+ 0.64 mm silicone tube diameter 0.94 mm wider silicone segment diameter Silicone Box of 1

The Ritleng®+ intubation systemis a Class IIbmedical devicemanufactured by FCI S.A.S. - Notified Body: GMED CE n°0459.

Videos

You have X selected

Any Questions ?

For more information about FCI offer or to get in touch with your local distributor,
please contact us. We will be in touch with you shortly.